Chemical Platforms for Peptide Vaccine Constructs

被引:5
|
作者
Ramesh, Suhas [1 ]
Cherkupally, Prabhakar [1 ]
Govender, Thavendran [1 ]
Kruger, Hendrik G. [1 ]
Albericio, Fernando [1 ,2 ,3 ,4 ,5 ,6 ]
de la Torre, Beatriz G. [1 ,2 ]
机构
[1] Univ KwaZulu Natal, Catalysis & Peptide Res Unit, Sch Hlth Sci, Durban, South Africa
[2] Yachay Tech, Sch Chem, Yachay City Of Knowledge, Urcuqui, Ecuador
[3] Univ KwaZulu Natal, Sch Chem & Phys, Durban, South Africa
[4] CIBER BBN, Networking Ctr Bioengn Biomat & Nanomed, Barcelona, Spain
[5] Univ Barcelona, Dept Organ Chem, Barcelona, Spain
[6] Inst Res Biomed IRB Barcelona, Barcelona, Spain
来源
PEPTIDE AND PROTEIN VACCINES | 2015年 / 99卷
关键词
SWINE-FEVER VIRUS; T-CELL; DENDRITIC CELLS; CHEMOSELECTIVE LIGATION; SYNTHETIC PEPTIDES; IMMUNE-RESPONSES; FACILE SYNTHESIS; DELIVERY-SYSTEM; INFLUENZA-VIRUS; IN-VITRO;
D O I
10.1016/bs.apcsb.2015.03.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Knowledge of the sequences and structures of proteins from pathogenic microorganisms has been put to great use in the field of protein chemistry for the development of peptide-based vaccines. These vaccine constructs include chemically tailored, shorter peptidic fragments that can induce high immunogenicity, thus shunning the allergenic and nonimmunogenic part of the antigens. Based on this concept, several different chemistries have been pursued to obtain novel platforms onto which antigenic epitopes can be tethered, with the aim to achieve a higher antibody response. In this regard, here we attempt to summarize the chemical strategies developed for the presentation of peptide epitopes.
引用
收藏
页码:99 / 130
页数:32
相关论文
共 50 条
  • [1] Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
    Schmidt, Christin
    Schnierle, Barbara S.
    PATHOGENS, 2023, 12 (01):
  • [2] Vaccine adjuvants: mechanisms and platforms
    Zhao, Tingmei
    Cai, Yulong
    Jiang, Yujie
    He, Xuemei
    Wei, Yuquan
    Yu, Yifan
    Tian, Xiaohe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [3] Vaccine platforms for the prevention of Lassa fever
    Purushotham, Jyothi
    Lambe, Teresa
    Gilbert, Sarah C.
    IMMUNOLOGY LETTERS, 2019, 215 : 1 - 11
  • [4] COVID-19 vaccine platforms: Delivering on a promise?
    Verdecia, Mark
    Kokai-Kun, John F.
    Kibbey, Maura
    Acharya, Sarita
    Venema, Jaap
    Atouf, Fouad
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2873 - 2893
  • [5] PEPTIDE VACCINE
    Izumoto, Shuichi
    GLIOMA: IMMUNOTHERAPEUTIC APPROACHES, 2012, 746 : 166 - 177
  • [6] Nanoparticle-based delivery platforms for mRNA vaccine development
    Okay, Sezer
    Ozcan, Oznur Ozge
    Karahan, Mesut
    AIMS BIOPHYSICS, 2020, 7 (04): : 323 - 338
  • [7] Vaccine platforms to control Lassa fever
    Lukashevich, Igor S.
    Pushko, Peter
    EXPERT REVIEW OF VACCINES, 2016, 15 (09) : 1135 - 1150
  • [8] The use of signal peptide domains as vaccine candidates
    Kovjazin, Riva
    Carmon, Lior
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (09) : 2733 - 2740
  • [9] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
    Mendonca, Samir Andrade
    Lorincz, Reka
    Boucher, Paul
    Curiel, David T.
    NPJ VACCINES, 2021, 6 (01)
  • [10] Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms
    Chountoulesi, Maria
    Pispas, Stergios
    Tseti, Ioulia K.
    Demetzos, Costas
    PHARMACEUTICALS, 2022, 15 (04)